Downloads
Revenue

Description

汇大云医是一款专注于慢病管理的APP。慢病是一种需要长期管理的疾病,很多患者由于缺乏足够的疾病知识和自我管理能力,在离开医院后又无法及时得到医生的指导,导致疾病管理效果差,各项指标不达标,甚至产生严重的并发症。汇大云医赋能医生在线高效管理慢病患者,帮助他们答疑解惑,科学管理疾病。与此同时,医生也能通过汇大云医积累粉丝,打造品牌,在帮助患者的同时获得阳光收入。

【功能介绍】

- 医生通过个人专属二维码添加患者
- 根据实际情况将患者进行分组,有针对性地进行管理。比如,针对糖尿病患者设定血糖控制目标和监测频率,推送糖尿病相关知识等
- 查看患者详细资料,并为患者填写医学信息
- 语音、文字和图片等形式进行医患沟通
- 查看项目进展
- 查看和编辑个人资料
Hide Show More...

Screenshots

汇大云医 FAQ

  • Is 汇大云医 free?

    Yes, 汇大云医 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is 汇大云医 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does 汇大云医 cost?

    汇大云医 is free.

  • What is 汇大云医 revenue?

    To get estimated revenue of 汇大云医 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Switzerland yet.
Ratings History

汇大云医 Reviews

No Reviews in Switzerland
App doesn't have any reviews in Switzerland yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

汇大云医 Competitors

Name
N/A
N/A
慧医天下医生版
早诊早治
早诊早治助力早癌防治事业
AnyMed医生版
鹿管家医生端
家庭医生好助手,健康管理好管家!
宝迪沃·医生 for 医生版
山东省中医院医护版
掌控糖尿病医生版-糖尿病医生助手
惠医生
三甲医疗团队,专业数字健康管理
宁医服

汇大云医 Installs

Last 30 days

汇大云医 Revenue

Last 30 days

汇大云医 Revenue and Downloads

Gain valuable insights into 汇大云医 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Languages
English, Chinese
Recent release
1.4.0 (3 years ago )
Released on
Jul 4, 2020 (4 years ago )
Last Updated
3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.